Leaflet TARUZA 1mg tablets

Product code:
W68950002
Quantity:
30
Indicated for:
hypertension
Route of administration:
oral
Substance:
rilmenidine (antihypertensive)
ATC
C02AC06 — Cardiovascular system | Antiadrenergic agents, centrally acting | Imidazoline receptor agonists
Rilmenidine is a medication used for the treatment of high blood pressure. It works by stimulating imidazoline receptors in the central nervous system, reducing sympathetic activity and lowering blood pressure.

The medication is taken orally, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular check-ups to monitor blood pressure.

Patients should be aware of potential side effects, such as fatigue, dry mouth, or dizziness. It is important to inform the doctor of any unusual symptoms.

Common side effects include fatigue, dry mouth, and dizziness. In rare cases, severe reactions such as bradycardia or severe hypotension may occur. Patients should be informed of these risks before starting treatment.

General data about TARUZA 1mg

Substance:
rilmenidine
Date of latest medicines list:
01-06-2026
Product code:
W68950002
Concentration:
1mg
Pharmaceutical form:
tablets
Quantity:
30
Product type:
Generic medicine
Price:
23.70 RON
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

Manufacturer:
ZENTIVA S.A. - ROMANIA
Holder:
ZENTIVA, K.S. - REPUBLICA CEHA
Number:
14512/2022/02
Shelf life:
2 years

Compensation lists for TARUZA 1mg Zentiva

B - Sublist B with 50% discount from the reference price

Price
23.70 RON
Copayment
11.85 RON
Patient
11.85 RON